Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab and Lenalidomide in Rituximab-Exposed CLL
NCT01123356Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab, lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by Medical University of South Carolina. Started May 2010; status: completed.
02
Drugs
ofatumumablenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01123356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123356.